| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.019 | 0.9 |